Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
Arthritis Drug market report explains the definition, types, applications, major countries, and major players of the Arthritis Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GSK
Novartis
Pfizer
Eli Lilly
Celltrion
F Hoffmann-La Roche
Johnson & Johnson
By Type:
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
By End-User:
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Arthritis Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Arthritis Drug Outlook to 2028- Original Forecasts
-
2.2 Arthritis Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Arthritis Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Arthritis Drug Market- Recent Developments
-
6.1 Arthritis Drug Market News and Developments
-
6.2 Arthritis Drug Market Deals Landscape
7 Arthritis Drug Raw Materials and Cost Structure Analysis
-
7.1 Arthritis Drug Key Raw Materials
-
7.2 Arthritis Drug Price Trend of Key Raw Materials
-
7.3 Arthritis Drug Key Suppliers of Raw Materials
-
7.4 Arthritis Drug Market Concentration Rate of Raw Materials
-
7.5 Arthritis Drug Cost Structure Analysis
-
7.5.1 Arthritis Drug Raw Materials Analysis
-
7.5.2 Arthritis Drug Labor Cost Analysis
-
7.5.3 Arthritis Drug Manufacturing Expenses Analysis
8 Global Arthritis Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Arthritis Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Arthritis Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Arthritis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Arthritis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Synthetic DMARDs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Biological DMARDs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NSAIDs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Analgesics Consumption and Growth Rate (2017-2022)
-
9.2 Global Arthritis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.4 Global E-Commerce Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Arthritis Drug Market Analysis and Outlook till 2022
-
10.1 Global Arthritis Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Arthritis Drug Consumption (2017-2022)
-
10.2.2 Canada Arthritis Drug Consumption (2017-2022)
-
10.2.3 Mexico Arthritis Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Arthritis Drug Consumption (2017-2022)
-
10.3.2 UK Arthritis Drug Consumption (2017-2022)
-
10.3.3 Spain Arthritis Drug Consumption (2017-2022)
-
10.3.4 Belgium Arthritis Drug Consumption (2017-2022)
-
10.3.5 France Arthritis Drug Consumption (2017-2022)
-
10.3.6 Italy Arthritis Drug Consumption (2017-2022)
-
10.3.7 Denmark Arthritis Drug Consumption (2017-2022)
-
10.3.8 Finland Arthritis Drug Consumption (2017-2022)
-
10.3.9 Norway Arthritis Drug Consumption (2017-2022)
-
10.3.10 Sweden Arthritis Drug Consumption (2017-2022)
-
10.3.11 Poland Arthritis Drug Consumption (2017-2022)
-
10.3.12 Russia Arthritis Drug Consumption (2017-2022)
-
10.3.13 Turkey Arthritis Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Arthritis Drug Consumption (2017-2022)
-
10.4.2 Japan Arthritis Drug Consumption (2017-2022)
-
10.4.3 India Arthritis Drug Consumption (2017-2022)
-
10.4.4 South Korea Arthritis Drug Consumption (2017-2022)
-
10.4.5 Pakistan Arthritis Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Arthritis Drug Consumption (2017-2022)
-
10.4.7 Indonesia Arthritis Drug Consumption (2017-2022)
-
10.4.8 Thailand Arthritis Drug Consumption (2017-2022)
-
10.4.9 Singapore Arthritis Drug Consumption (2017-2022)
-
10.4.10 Malaysia Arthritis Drug Consumption (2017-2022)
-
10.4.11 Philippines Arthritis Drug Consumption (2017-2022)
-
10.4.12 Vietnam Arthritis Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Arthritis Drug Consumption (2017-2022)
-
10.5.2 Colombia Arthritis Drug Consumption (2017-2022)
-
10.5.3 Chile Arthritis Drug Consumption (2017-2022)
-
10.5.4 Argentina Arthritis Drug Consumption (2017-2022)
-
10.5.5 Venezuela Arthritis Drug Consumption (2017-2022)
-
10.5.6 Peru Arthritis Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Arthritis Drug Consumption (2017-2022)
-
10.5.8 Ecuador Arthritis Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Arthritis Drug Consumption (2017-2022)
-
10.6.2 Kuwait Arthritis Drug Consumption (2017-2022)
-
10.6.3 Oman Arthritis Drug Consumption (2017-2022)
-
10.6.4 Qatar Arthritis Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Arthritis Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Arthritis Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Arthritis Drug Consumption (2017-2022)
-
10.7.2 South Africa Arthritis Drug Consumption (2017-2022)
-
10.7.3 Egypt Arthritis Drug Consumption (2017-2022)
-
10.7.4 Algeria Arthritis Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Arthritis Drug Consumption (2017-2022)
-
10.8.2 New Zealand Arthritis Drug Consumption (2017-2022)
11 Global Arthritis Drug Competitive Analysis
-
11.1 GSK
-
11.1.1 GSK Company Details
-
11.1.2 GSK Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GSK Arthritis Drug Main Business and Markets Served
-
11.1.4 GSK Arthritis Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Novartis
-
11.2.1 Novartis Company Details
-
11.2.2 Novartis Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Novartis Arthritis Drug Main Business and Markets Served
-
11.2.4 Novartis Arthritis Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pfizer
-
11.3.1 Pfizer Company Details
-
11.3.2 Pfizer Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pfizer Arthritis Drug Main Business and Markets Served
-
11.3.4 Pfizer Arthritis Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eli Lilly
-
11.4.1 Eli Lilly Company Details
-
11.4.2 Eli Lilly Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eli Lilly Arthritis Drug Main Business and Markets Served
-
11.4.4 Eli Lilly Arthritis Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Celltrion
-
11.5.1 Celltrion Company Details
-
11.5.2 Celltrion Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Celltrion Arthritis Drug Main Business and Markets Served
-
11.5.4 Celltrion Arthritis Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 F Hoffmann-La Roche
-
11.6.1 F Hoffmann-La Roche Company Details
-
11.6.2 F Hoffmann-La Roche Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 F Hoffmann-La Roche Arthritis Drug Main Business and Markets Served
-
11.6.4 F Hoffmann-La Roche Arthritis Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Johnson & Johnson
-
11.7.1 Johnson & Johnson Company Details
-
11.7.2 Johnson & Johnson Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Johnson & Johnson Arthritis Drug Main Business and Markets Served
-
11.7.4 Johnson & Johnson Arthritis Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
12 Global Arthritis Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Arthritis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Synthetic DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Biological DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Arthritis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Arthritis Drug Market Analysis and Outlook to 2028
-
13.1 Global Arthritis Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Arthritis Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Arthritis Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Arthritis Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.5 France Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Arthritis Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Arthritis Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.3 India Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Arthritis Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Arthritis Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Arthritis Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Arthritis Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Arthritis Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Arthritis Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Arthritis Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Arthritis Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Arthritis Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Arthritis Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Arthritis Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Arthritis Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Arthritis Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Arthritis Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Arthritis Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Arthritis Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Arthritis Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Arthritis Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Arthritis Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Arthritis Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Arthritis Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Arthritis Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Arthritis Drug
-
Figure of Arthritis Drug Picture
-
Table Global Arthritis Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Arthritis Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Synthetic DMARDs Consumption and Growth Rate (2017-2022)
-
Figure Global Biological DMARDs Consumption and Growth Rate (2017-2022)
-
Figure Global NSAIDs Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global E-Commerce Consumption and Growth Rate (2017-2022)
-
Figure Global Arthritis Drug Consumption by Country (2017-2022)
-
Table North America Arthritis Drug Consumption by Country (2017-2022)
-
Figure United States Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Arthritis Drug Consumption by Country (2017-2022)
-
Figure Germany Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure France Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Arthritis Drug Consumption by Country (2017-2022)
-
Figure China Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table South America Arthritis Drug Consumption by Country (2017-2022)
-
Figure Brazil Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Arthritis Drug Consumption by Country (2017-2022)
-
Figure Bahrain Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Arthritis Drug Consumption by Country (2017-2022)
-
Figure Nigeria Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Arthritis Drug Consumption by Country (2017-2022)
-
Figure Australia Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Arthritis Drug Consumption and Growth Rate (2017-2022)
-
Table GSK Company Details
-
Table GSK Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Arthritis Drug Main Business and Markets Served
-
Table GSK Arthritis Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Arthritis Drug Main Business and Markets Served
-
Table Novartis Arthritis Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Arthritis Drug Main Business and Markets Served
-
Table Pfizer Arthritis Drug Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Arthritis Drug Main Business and Markets Served
-
Table Eli Lilly Arthritis Drug Product Portfolio
-
Table Celltrion Company Details
-
Table Celltrion Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Arthritis Drug Main Business and Markets Served
-
Table Celltrion Arthritis Drug Product Portfolio
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Arthritis Drug Main Business and Markets Served
-
Table F Hoffmann-La Roche Arthritis Drug Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Arthritis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Arthritis Drug Main Business and Markets Served
-
Table Johnson & Johnson Arthritis Drug Product Portfolio
-
Figure Global Synthetic DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biological DMARDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NSAIDs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Table North America Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure China Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Arthritis Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Arthritis Drug Consumption Forecast and Growth Rate (2022-2028)
-
